ScinoPharm Taiwan, Ltd. (1789.TW)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap21.86B
EV21.86B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
134.8
130.1
132.6
115.7
115.9
95.1
101.4
90.8
107.3
104.4
Revenue % Chg.
-19.5%
-3.5%
1.9%
-12.8%
0.2%
-17.9%
6.6%
-10.4%
18.2%
11.0%
Cost of Revenue
82.1
74.9
73.2
64.7
65.2
56.4
58.1
48.7
66.2
65.0
Gross Profit
52.6
55.1
59.4
51.0
50.7
38.7
43.3
42.1
41.1
39.4
Gross Profit Margin
39.1%
42.4%
44.8%
44.1%
43.8%
40.7%
42.7%
46.4%
38.3%
37.7%
R&D Expenses
13.7
10.7
9.2
10.3
10.3
7.8
8.1
10.1
8.9
9.8
Selling, General, & Admin Expenses
20.6
19.8
21.6
22.3
22.1
22.1
22.9
22.6
18.9
17.5
Operating Income
18.4
24.7
28.6
18.4
18.4
10.6
12.3
10.2
14.7
13.2
Operating Income Margin
13.7%
19.0%
21.5%
15.9%
15.8%
11.1%
12.1%
11.2%
13.7%
12.7%
Total Other Income/Expenses Net
1.4
1.7
-1.9
-2.8
-2.2
-1.8
-0.5
-0.2
-0.3
-0.3
Income Before Tax
19.8
26.4
26.7
15.6
16.1
8.7
11.8
9.9
14.4
13.0
Income Before Tax Margin
14.7%
20.3%
20.1%
13.5%
13.9%
9.2%
11.6%
10.9%
13.4%
12.4%
Income Tax Expense
3.9
5.5
5.0
1.7
1.6
1.6
2.5
1.9
2.8
2.5
Net Income
15.9
20.9
21.7
13.9
14.6
7.1
9.3
8.0
11.6
10.5
Net Income Margin
11.8%
16.1%
16.3%
12.0%
12.6%
7.5%
9.1%
8.8%
10.8%
10.0%
Weighted Avg. Shares Out
790.7
790.7
790.7
790.7
790.7
790.7
790.7
790.7
790.7
779.5
EPS
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS % Chg.
-61.8%
31.1%
4.0%
-36.6%
5.7%
-51.8%
33.3%
-13.9%
45.2%
42.5%
Weighted Avg. Shares Out Dil
790.7
792.2
793.8
792.6
793.1
792.1
792.2
792.3
790.7
779.8
EPS Diluted
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Interest Income
—
—
—
—
—
—
0.9
0.6
0.7
1.0
Interest Expense
0.1
0.3
1.2
2.5
2.6
1.8
0.5
0.2
0.3
0.3
EBIT
19.7
26.1
25.5
13.1
13.5
6.9
12.2
10.4
14.9
13.7
EBIT Margin
14.6%
20.1%
19.2%
11.3%
11.6%
7.2%
12.0%
11.4%
13.9%
13.1%
Depreciation & Amortization
15.5
15.9
14.6
14.2
13.3
13.4
12.9
12.5
14.5
15.1
EBITDA
35.2
42.0
40.1
27.3
26.8
20.3
25.1
22.9
29.3
28.8
EBITDA Margin
26.1%
32.3%
30.2%
23.6%
23.2%
21.4%
24.8%
25.2%
27.3%
27.6%